Literature DB >> 26631303

Medical Professional Liability in Psychiatry.

Carles Martin-Fumadó1, Esperanza L Gómez-Durán2, Manuel Rodríguez-Pazos3, Josep Arimany-Manso4.   

Abstract

INTRODUCTION: The safety of patients and the risk of malpractice claims are overriding concerns in medicine and psychiatry.
MATERIAL AND METHODS: Claims for alleged malpractice in psychiatry managed by the Council of Colleges of Physicians of Catalonia between 1986 and 2009 were analyzed to evaluate their clinical and legal characteristics.
RESULTS: Ninety-four malpractice claims were found in a 23-year period, mainly claims related to diagnosis (63.83%, including assessment of suicide risk) and the legal figure of serious professional negligence resulting in death (46.8%). Most claims were for hospital (62.77%), emergency (52.5%), and team (53.75%) care. The possible affected party was male (51.58%) with a mean age of 36.6 years. In one-half of the cases, the harm claimed was death. The cases involved 139 specialists, predominantly male (69.57%), with a mean age of 41 years, and of Spanish nationality (91.4%). The time between the medical act and the respective claim was 1.28 years and the time to resolution was 2.68 years. Most of the cases (77.66%) were processed through the courts. The outcome of the cases was filing or dismissal in 91 (95.77%), conviction in 2 (2.81%), and settlement in 1 (1.41%).
CONCLUSIONS: The cumulative incidence of 0.013 claims (1.35%) in 23 years suggests that there is a very low risk of lawsuits in psychiatry, with a similarly low rate of sentences of professional liability and awards for financial compensation. Specific actions could improve clinical safety, particularly in suicide risk assessment.

Entities:  

Mesh:

Year:  2015        PMID: 26631303

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  1 in total

1.  Cross-sectional survey on defensive practices and defensive behaviours among Israeli psychiatrists.

Authors:  I Reuveni; I Pelov; H Reuveni; O Bonne; L Canetti
Journal:  BMJ Open       Date:  2017-03-20       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.